Binodh DeSilva

Statistics

Publications

Citations

3.4K

H-Index

Active since

1995

Affiliations

Bristol-Myers Squibb (United States)(Current)

Amgen (United States)

Bristol-Myers Squibb (Germany)

United States Food and Drug Administration

Merck & Co., Inc., Rahway, NJ, USA (United States)

Binodh DeSilva is an author at Bristol-Myers Squibb (United States) specializing in pharmacy, bioanalytical method validation, and bioanalytical chemistry.

ORCID

Publications per year

1995–2022

Publications

Recommendations for the Bioanalytical Method Validation of Ligand-Binding Assays to Support Pharmacokinetic Assessments of Macromolecules

Binodh DeSilva, Wendell C. Smith, Russell Weiner et al. · Pharmaceutical Research · 2003 · 614 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +14

Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective

John W. A. Findlay, W. Smith, J.W. Lee et al. · Journal of Pharmaceutical and Biomedical Analysis · 2000 · 582 citations

Pharmacy, Pharmaceutical Analysis, Pharmaceutics +11

Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2

Jonathan D. Oliner, Hosung Min, Juan Leal et al. · Cancer Cell · 2004 · 469 citations · Full text

Medicine, Cancer Biology, Oncology +14

Key elements of bioanalytical method validation for macromolecules

Marian Kelley, Binodh DeSilva · The AAPS Journal · 2007 · 153 citations · Full text

Pharmacy, Biochemistry, Analytical Chemistry +12

Workshop Report: Crystal City V—Quantitative Bioanalytical Method Validation and Implementation: The 2013 Revised FDA Guidance

Brian Booth, Mark E. Arnold, Binodh DeSilva et al. · The AAPS Journal · 2014 · 114 citations

Pharmacy, Pharmaceutics, Analytical Chemistry +13

1–5 of 49